Recorded fact · drug.trial_access

drug.trial_access for abatacept

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 240ee323 resolves to.

The record

Fact id	`240ee3234816564fdd5c8946`
Entity	drug: abatacept
Field	drug.trial_access
Source	clinicaltrials.gov
Read on	2026-11-07T06:34:32.466Z
Source version	clinicaltrials-api-2.0.5-data-2026-11-06T10:00:05
Method	api
Verification	machine_read
Licence	Terms and Conditions (last updated 2023-01-31) READ in full 2026-11-07: data free to all requesters; reuse allowed on conditions: attribute ClinicalTrials.gov, keep data current, display the date the registry processed the data, state any modifications; do not represent the data as other than a US Government database; no use of extracted email addresses for marketing; some records may carry third-party copyright (consult the submitter) and the data carry an international copyright outside the US. API rate guidance page UNREAD (JS page rendered no text 2026-11-07). AMBER because of the third-party copyright caveat on submitter text; counts and ids are safe, long free text is not reproduced. \| DISPLAY CONDITIONS (any page or delivery using this source): attribute ClinicalTrials.gov, show the registry processing date, state our modifications, never present as other than a US Government database, never use extracted emails for marketing.
Edition	2026-11, Merkle root `006ab9a329709cbe...`

This fact carries no verifying quote; its source is the dataset named above.

The value

{
 "ingredient": "ABATACEPT",
 "recruitingInterventionalCount": 33,
 "notYetRecruitingCount": 1,
 "byPhase": {
  "EARLY_PHASE1": 1,
  "PHASE1/PHASE2": 6,
  "PHASE1": 3,
  "PHASE2": 12,
  "PHASE3": 7,
  "PHASE4": 2,
  "PHASE2/PHASE3": 2
 },
 "trials": [
  {
   "nctId": "NCT06731504",
   "briefTitle": "HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT",
   "phase": [
    "EARLY_PHASE1"
   ],
   "leadSponsor": "Duke University",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-06",
   "startDate": "2025-11-12",
   "conditions": [
    "Hematologic Malignancy"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06731504"
  },
  {
   "nctId": "NCT07675174",
   "briefTitle": "PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT",
   "phase": [
    "PHASE1",
    "PHASE2"
   ],
   "leadSponsor": "Northwell Health",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-06",
   "startDate": "2026-08-14",
   "conditions": [
    "GVHD - Graft-Versus-Host Disease"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07675174"
  },
  {
   "nctId": "NCT06918990",
   "briefTitle": "Treatment of Antibody-Mediated Rejection (ABMR) With CarBel",
   "phase": [
    "PHASE1"
   ],
   "leadSponsor": "National Institute of Allergy and Infectious Diseases (NIAID)",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-23",
   "startDate": "2026-05-27",
   "conditions": [
    "Kidney Transplant Rejection"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06918990"
  },
  {
   "nctId": "NCT06055608",
   "briefTitle": "Advancing Transplantation Outcomes in Children",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "National Institute of Allergy and Infectious Diseases (NIAID)",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-23",
   "startDate": "2024-05-22",
   "conditions": [
    "Kidney Transplant"
   ],
   "countries": [
    "United States",
    "Canada"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06055608"
  },
  {
   "nctId": "NCT06654882",
   "briefTitle": "Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Duke University",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-21",
   "startDate": "2026-01-09",
   "conditions": [
    "Polyarticular Course Juvenile Idiopathic Arthritis (JIA)"
   ],
   "countries": [
    "United States",
    "Germany",
    "Italy",
    "Netherlands"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06654882"
  },
  {
   "nctId": "NCT07388563",
   "briefTitle": "Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma",
   "phase": [
    "PHASE1"
   ],
   "leadSponsor": "National Cancer Institute (NCI)",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-20",
   "startDate": "2026-03-26",
   "conditions": [
    "Lymphoma, T Cell, Peripheral",
    "T-cell Lymphoma",
    "Angioimmunoblastic T-cell Lymphoma"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07388563"
  },
  {
   "nctId": "NCT07599176",
   "briefTitle": "Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors",
   "phase": [
    "PHASE1",
    "PHASE2"
   ],
   "leadSponsor": "National Heart, Lung, and Blood Institute (NHLBI)",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-13",
   "startDate": "2026-07-08",
   "conditions": [
    "Sickle Cell Disease",
    "Beta-thalassemia"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07599176"
  },
  {
   "nctId": "NCT06478017",
   "briefTitle": "Belatacept in Heart Transplantation",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "National Institute of Allergy and Infectious Diseases (NIAID)",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-09",
   "startDate": "2025-01-29",
   "conditions": [
    "Heart Transplant"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06478017"
  },
  {
   "nctId": "NCT04692493",
   "briefTitle": "RA-PRO PRAGMATIC TRIAL",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "University of Alabama at Birmingham",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-24",
   "startDate": "2021-09-22",
   "conditions": [
    "Rheumatoid Arthritis"
   ],
   "countries": [
    "United States",
    "Canada"
   ],
   "url": "https://clinicaltrials.gov/study/NCT04692493"
  },
  {
   "nctId": "NCT00920972",
   "briefTitle": "Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases",
   "phase": [
    "PHASE1",
    "PHASE2"
   ],
   "leadSponsor": "Washington University School of Medicine",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-16",
   "startDate": "2001-12",
   "conditions": [
    "Metabolic Disorders",
    "Hematologic, Immune, or Bone Marrow Disorders",
    "Hemoglobinopathies"
   ],
   "countries": [
    "United States",
    "Canada"
   ],
   "url": "https://clinicaltrials.gov/study/NCT00920972"
  },
  {
   "nctId": "NCT04877288",
   "briefTitle": "A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Bristol-Myers Squibb",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-08-31",
   "startDate": "2021-07-21",
   "conditions": [
    "Renal Allograft Recipients"
   ],
   "countries": [
    "United States",
    "Argentina",
    "Belgium",
    "France",
    "Germany",
    "Italy",
    "Netherland
... (shortened here; the full value is in the JSON twin)

SHA-256 of the exact stored value: dc0962d0a2216711566f6a7bf67d072c02809ef58aef004859c8cc1c094a2951.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.